You have 9 free searches left this month | for more free features.

Acalabrutinib

Showing 126 - 137 of 137

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL/SLL Trial in Australia, United States (APG2575)

Recruiting
  • CLL/SLL
  • Duarte, California
  • +8 more
Feb 28, 2022

Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
  • (no location specified)
Dec 27, 2022

Metastatic Pancreatic Cancer Trial in United States (ACP-196, Nab-paclitaxel, Gemcitabine)

Terminated
  • Metastatic Pancreatic Cancer
  • Ventura, California
  • +9 more
Aug 23, 2019

Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +9 more
    Mar 4, 2022

    Chronic Lymphoid Leukemia Trial in France (Ambulatory medical assistance)

    Not yet recruiting
    • Chronic Lymphoid Leukemia
    • Ambulatory medical assistance
    • Saint Pierre, ILE DE LA Reunion, France
    • +15 more
    Jul 29, 2022

    Rheumatoid Arthritis Trial in United States (acalabrutinib, Placebo)

    Completed
    • Rheumatoid Arthritis
    • acalabrutinib
    • Placebo
    • Anniston, Alabama
    • +16 more
    Mar 25, 2019

    Quality of Life of Lymphomas Treated With Oral Therapy

    Recruiting
    • Quality of Life
    • Questionnaire
    • Toulouse 9, France
      Loïc YSEBAERT
    Apr 22, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived

    Unknown status
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Best Practice
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 23, 2020

    CAP-100 for Relapsed/Refractory Chronic Lymphocytic Leukemia

    Recruiting
    • Lymphocytic Leukemia, Chronic
    • SLL
    • Durham, North Carolina
    • +1 more
    Sep 16, 2021

    Mantle Cell Lymphoma Trial (acalabrutinib, ibrutinib, rituximab)

    Withdrawn
    • Mantle Cell Lymphoma
    • acalabrutinib
    • +2 more
    • (no location specified)
    May 12, 2016